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Abstract
Background: Increased scarcity of public resources has led to a concomitant drive to account for value-for-money
of interventions. Traditionally, cost-effectiveness, cost-utility and cost-benefit analyses have been used to assess
value-for-money of public health interventions. The social return on investment (SROI) methodology has capacity to
measure broader socio-economic outcomes, analysing and computing views of multiple stakeholders in a singular
monetary ratio. This review provides an overview of SROI application in public health, explores lessons learnt from
previous studies and makes recommendations for future SROI application in public health.
Methods: A systematic review of peer-reviewed and grey literature to identify SROI studies published between
January 1996 and December 2014 was conducted. All articles describing conduct of public health SROI studies and
which reported a SROI ratio were included. An existing 12-point framework was used to assess study quality. Data
were extracted using pre-developed codes: SROI type, type of commissioning organisation, study country, public
health area in which SROI was conducted, stakeholders included in study, discount rate used, SROI ratio obtained,
time horizon of analysis and reported lessons learnt.
Results: 40 SROI studies, of varying quality, including 33 from high-income countries and 7 from low middle-income
countries, met the inclusion criteria. SROI application increased since its first use in 2005 until 2011, declining afterwards.
SROI has been applied across different public health areas including health promotion (12 studies), mental health (11),
sexual and reproductive health (6), child health (4), nutrition (3), healthcare management (2), health education and
environmental health (1 each). Qualitative and quantitative methods have been used to gather information for public
health SROI studies. However, there remains a lack of consensus on who to include as beneficiaries, how to account for
counterfactual and appropriate study-time horizon.
Reported SROI ratios vary widely (1.1:1 to 65:1).
Conclusions: SROI can be applied across healthcare settings. Best practices such as analysis involving only beneficiaries
(not all stakeholders), providing justification for discount rates used in models, using purchasing power parity
equivalents for monetary valuations and incorporating objective designs such as case–control or before-and-after
designs for accounting for outcomes will improve robustness of public health SROI studies.
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Table 1 Comparison of SROI with traditional economic evaluation frameworks
Cost-Effectiveness
Analysis (CEA)
Cost-Utility Analysis (CUA) Sub-type of CEA Cost-Benefit Analysis (CBA) Social Return on Investment (SROI)
Main objective
To compare costs and
impact of alternatives
within the same domain
To compare costs and impact of alternatives
within the same domain
To assess if an intervention is
worth the investment.
To assess if an intervention is worth
the investment.
Costs
Monetary value Monetary value Monetary value Monetary value
Benefits
Benefits linked to health
improvements.
Benefits linked to health improvements. Captures health and non-health
impacts.
Captures health and non-health
impacts, underpinned by the “triple
bottom line”
approach (social, economic and
environmental). In addition, seeks to
account for and value potential
negative effect of interventions.
Reported as natural units
E.g. lives saved or cases
averted
Reported as Quality Adjusted Life Years
(QALYs) gained/ Disability Adjusted Life Years
(DALYs) averted/ Healthy life-years gained
Reported as monetary value or
welfare benefit
Reported as monetary value or welfare
benefit
Lists benefits that cannot be
easily monetised and explains
why they cannot be monetised
Uses financial proxies to estimate
monetary value of benefits that
cannot be easily monetised
Level of application
Intervention level Intervention level Usually intervention level Intervention, project, programme,
policy or organisation level
Timeline of analysis
Retrospective or
Prospective
Retrospective or Prospective Retrospective or Prospective Retrospective or Prospective
Discounting of future value
Yes Yes Yes Yes
Stakeholder engagement
No No No Yes
Theory of change
No No No Yes
Main output of analysis
Incremental Cost-
Effectiveness Ratio (ICER)
Incremental Cost-Effectiveness Ratio (ICER) Benefit-Cost Ratio (BCR) Social Return on Investment Ratio
Economic Internal Rate of Return
(EIRR)
Net Present Value (NPV)
Net Present Value (NPV) Payback period
Break-even point
Interpretation of main output of analysis
Intervention with higher
cost-effectiveness ratio is
better
Intervention with higher cost-effectiveness ra-
tio is better
BCR > 1 is worthwhile
investment
SROI ratio > 1 is worthwhile
investment
Relevance
Priority setting and
resource allocation
Priority setting and resource allocation Priority setting and resource
allocation
Priority setting
Resource allocation
Stakeholder relationship building,
Accountability framework,
Management tool
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Background
Recognising the need to institute a culture of account-
ability, funders of public healt interventions and national
governments are demanding “value for money” (VfM) of
interventions, to ensure both economic and social effi-
ciency and better allocation of resources for the wider
good of the people [1–3]. It is important and timely to
review assessment frameworks that attempt to demon-
strate this value and their applicability in the public
health area.
Traditionally, frameworks such as cost-effectiveness
analysis (CEA), cost-utility analysis (CUA) and cost-
benefit analysis (CBA) have been used [4]. However, in
recent times, social return on investment (SROI) meth-
odology has been promoted as a more ‘holistic’ approach
to demonstrating VfM [5–7]. A comparison of the differ-
ent approaches is provided in Table 1.
In the most recent SROI methodology guidance, SROI
is defined as “a framework for measuring and accounting
for the much broader concept of value. It seeks to re-
duce inequality and environmental degradation and im-
prove wellbeing by incorporating social, environmental
and economic costs and benefits” [8]. SROI is a process
for understanding, measuring, and reporting the social,
economic and environmental value created by an inter-
vention, programme, policy or organisation [9]. SROI
can retrospectively measure outcomes that have already
occurred (evaluative-type) or can prospectively predict
how much value will be generated if the intervention
meets its intended outcomes (forecast-type) [8]. Data
collection and subsequent analyses allow calculation of a
benefits-to-costs ratio [8]. For example, a ratio of 4:1 in-
dicates that an investment of £1 delivers £4 of social
value.
The SROI framework was first developed by the Roberts
Enterprise Development Fund (REDF) in 1996 [10], after
which there has been a gradual revision of the original
methodology [11]. These revisions have led to an integra-
tion of REDF‘s original SROI methodology (a social im-
pact measurement tool) with principles and processes
normally used in economic evaluations and financial re-
turn on investment to build a framework capable of cap-
turing the wider impact of interventions (social, economic
and environmental) [12]. This concept is widely referred
to as the “triple bottom line” [13], which is in itself under-
pinned by the “blended value accounting” theory [14].
Based on the most recent guideline [8], the conduct of a
SROI study requires progression through six stages
[Fig. 1].
Previous narrative reviews have appraised the SROI
methodology, putting forward its strengths (including cap-
acity to generate a singular ratio that captures both posi-
tive and negative outcomes, provision of platform for
meaningful engagement of multiple stakeholders and its
representation of stakeholder benefits in ways that are
unique to the stakeholders themselves) and weaknesses
Fig. 1 Stages of the SROI process
Banke-Thomas et al. BMC Public Health  (2015) 15:582 Page 3 of 14
(difficulty of attaching financial values to “soft outcomes”
and establishing what would have happened without the
intervention (the counterfactual) as well as poor compar-
ability of SROI ratios across interventions) [6, 7, 10, 15].
Two other reviews have compared SROI with social im-
pact measurement tools such as Social Accounting and
Auditing (SAA) and the Global Reporting Initiative (GRI)
highlighting that SROI is the only methodology that cap-
tures change across the whole spectrum of the theory of
change (input – impact) and provides a monetised ratio
[11, 16]. When compared to traditional economic evalu-
ation tools (CEA, CUA, CBA) [17, 18], SROI has been de-
scribed as an extension of the CBA to incorporate in
addition the broader socio-economic and environmental
outcomes [6, 7, 10, 11, 15]. SROI is able to achieve this
through its use of financial proxies, allowing complex out-
comes such as ‘reduced stigma for people living with HIV/
AIDS’ to be accounted for [19]. Another review compared
guidance on these methodologies for economic evaluation
of public health interventions including SROI, suggesting
that the techniques proposed for SROI guidance relate
well to public health [20]. Furthermore, there is a non-
peer reviewed narrative review that explores the applica-
tion of the SROI methodology across different sectors
[21]. However, there is no previous systematic review that
focuses on the application of SROI specifically in public
health.
We, therefore, conducted a systematic review of the
peer-reviewed and grey literature to identify and assess
studies in which the SROI methodology has been ap-
plied in public health, explore lessons learnt based on
previous applications and make recommendations for
future SROI application in public health.
Methods
We followed the PRISMA approach [22] to reporting
the findings of this systematic review of SROI applica-
tion of public health interventions [Additional file 1].
Search strategy
The preliminary search terms used were “social return
on investment” and “SROI”. After an initial review of
identified studies, the search terms were expanded to in-
clude: “blended value accounting”, “return on invest-
ment”, “ROI”, “economic return on investment”, “social
rates of return on investment”, "social value" and “social
impact". However, when used, not all terms were found
to be sensitive for “social return on investment”. Follow-
ing this exploration, the decision was made to use the
search terms “social return on investment”, “SROI” and
“blended value accounting” which were combined with
“health” OR “public health” within peer reviewed data-
bases (PubMed, Scopus and ProQuest).
For grey literature, SROI studies were identified via re-
view of titles, abstracts or executive summaries or full
text of articles found through web search (Google
Scholar) or from SROI focused databases (SROI Net-
work and new economics foundation (nef )).
For both peer reviewed and grey literature sources, we
searched for articles published from January 1996 and
December 2014. This time frame was chosen because
the first recorded SROI report was published in 1996.
We hand-searched the content pages of journal issues
and reports and checked reference lists of identified articles
to identify additional studies. Direct emails were sent to
practitioners, whose contact details were available in
executive summaries or websites that made reference to
conduct of a public health SROI study, to request reports
of these SROI studies. In addition, a public request was
made to relevant SROI interest online groups to ensure that
all public health SROI studies were potentially captured.
Two researchers independently conducted the search
and reviewed all retrieved records. Agreement was
reached regarding the final eligibility of articles based on
the set inclusion and exclusion criteria. Opinion of a third
reviewer was requested when consensus was not reached.
Inclusion and exclusion criteria
Public Health SROI articles from both peer-reviewed
and grey literature sources, published in English, which
described actual conduct of the study and included a
SROI ratio, from 1996 onward were included.
Articles that measured social impact using other ap-
proaches than SROI, reviews, commentaries and editorials
as well as articles that only referred to SROI without any
detail on actual conduct of a SROI were excluded.
Data extraction and synthesis
A pre-developed summary table was used to capture
year of publication, type of SROI study, country of or-
ganisation conducting or commissioning the SROI study,
type of commissioning organisation, country where
study was conducted, public health area in which SROI
was conducted, stakeholders included in study, stake-
holder classification, discount rate used in the study,
SROI ratio obtained, time horizon of analysis (Interven-
tion-Measurement) and reported lessons learnt. Missing
or unclear information was obtained by contacting the
author(s) of the SROI article directly, wherever possible.
Thematic summaries were used to configure and com-
pare information obtained. Findings retrieved from the
studies were summarised to map patterns in the application
of the SROI methodology in public health. To analyse in-
formation on lessons learnt with regard to limitations and
strengths of the methodology, the deductive approach of
framework synthesis [23] was used. Findings are presented
as emerging themes.
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Definitions
For the purpose of this review, a stakeholder was defined
as “a person who is affected by the work of an organisa-
tion or has contributed to the work” [24]. Borrowing
from previous stakeholder classification frameworks
[25–27], we defined the different types of stakeholders
as:
i. Beneficiaries: users, those who experience the
outcomes of an intervention.
ii. Implementers: includes project managers, suppliers
and subcontractors.
iii. Promoters: those who provide support and a
conducive environment for implementation of the
intervention.
iv. Funders: those who finance the project.
Quality assessment
A 12-point quality assessment framework, developed by Krlev
et al., [21] [Table 2] was used to assess quality of included
SROI studies. This framework proposed 5 quality dimensions:
I. Transparency about why SROI was chosen
II. Documentation of the analysis
III.Study design (approximation of counterfactual)
IV.Precision of the analysis and
V. Reflection of the results.
An award of 1 point was given to each criterion that
was adjudged “present” and 0 if the item was “missing”
or “could not be ascertained”. We used the 70 % bench-
mark, which Krlev et al. describe as a “good score”, clas-
sifying papers into high quality, if the study scored ≥
70 % and low quality, if the study scored < 70 %.
Results
A total of 40 SROI studies were identified; 82.5 % were
retrieved from grey literature, while 10 % were from
peer-reviewed journals. The remaining 7.5 % were from
online repositories of theses (Bachelors, Masters or
Doctorate) [Fig. 2].
Of the 40 included SROI studies, between 83 and 100 %
were awarded “1 point” for the presence of the specific
quality criteria across three quality dimensions: transpar-
ency about why SROI was chosen, documentation of the
analysis and precision of the analysis. However, with the
remaining two quality dimensions (study design [approxi-
mation of dead weight] and reflections of the result), per-
centages of studies with presence of specific criteria
ranged from 18 % to 48 %. The majority of studies did
meet the criteria ‘SROI ratio interpreted’ (100 %) and
‘sensitivity analysis performed’ (80 %) [Additional file 2].
For the criterion ‘study design (approximation of dead
weight)’, 8 studies used control groups [19, 28–34] (to
establish what would have happened without the inter-
vention, while another 8 studies used a before-and-after
study design [35–42]. The remainder of the studies
based the estimation on what would have happened
without the intervention on assumptions or on opinions
of the stakeholders that were engaged for the purpose of
the study [Additional file 2].
For the criterion ‘reflection of the result’, 19 studies
discussed the limitations of the study. Eight studies did
not conduct sensitivity analysis to test robustness of as-
sumptions used in the conduct of the study [29, 35, 40,
43–47]. However, all studies calculated and interpreted
the resultant SROI ratio [Additional file 2].
Out of a maximum of 12 that could be achieved, qual-
ity scores ranged from 3 to 11 (median 9). Twelve public
health SROI studies were considered to be of low quality
[28, 31, 37, 40, 41, 43, 45, 46, 48–51], while the
remaining 28 were of high quality [19, 29, 30, 32–36, 38,
39, 42, 44, 47, 52–66]
Distribution of SROI application in public health
The application of SROI in public health steeply in-
creased since its first use in the UK in 2005 [63] until
2011, after which there has been a decline [Fig. 3].
Table 2 Krlev et al’s 12-point quality assessment framework
Dimension number Dimension Criterion Description of
criterion
I Transparency about
why SROI was
chosen
1 Linked to context
discussion?
II Documentation of
the analysis
2 Analysis well
documented?
3 Impact map used?
III Study design
(approximation of
‘dead-weight’)
4 Control group
setup applied?
5 Ex ante - ex post
observations
performed?
IV Precision of the
analysis
6 Indicators valid &
comprehensive?
7 Proxies valid &
comprehensive?
8 Social effects
captured?
(Qualitatively)
9 Social effects
captured?
(Quantitatively)
V Reflection of the
results
10 Limitations
discussed?
11 SROI ratio
interpreted?
12 Sensitivity analysis
performed?
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Fig. 2 PRISMA flowchart summarising the search process
Fig. 3 Number of studies published by year in countries where SROI has been applied
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28 SROI studies in public health were conducted in the
UK [30, 32, 33, 37–42, 44–48, 50, 52–64]. Other countries
in which the SROI methodology has been applied in pub-
lic health are Australia [49, 65], Kenya [29, 34], Cambodia
[51], Canada [35], India [36], Netherlands [28], Tanzania
[43], United States of America [31], Zambia [19] and
Zimbabwe [66] [Fig. 3].
Characteristics of included studies
Different organisations and individuals within the public,
profit and non-profit sectors have used SROI to evaluate
a range of interventions in different areas of public
health [Additional file 3].
Across public health areas, health promotion (12)
[28, 30, 33, 39, 42, 46, 50, 60–62, 65, 66] and mental
health (11) [32, 37, 45, 47, 49, 52, 53, 55, 57, 58, 63]
are areas in which the SROI methodology has been
most applied. The methodology has also been applied
in sexual and reproductive health (SRH) (6) [19, 34,
38, 51, 54, 56], child health (4) [31, 36, 41, 43], nutri-
tion (3) [33, 44, 49] and to a smaller degree in health
care management (2) [35, 64], environmental health
(1) [29] and health education (1) [40] [Table 3].
26 of the retrieved SROI studies were evaluative-type
[29–36, 40, 42–46, 49–55, 60, 61, 63–65], while the
other 14 were forecast-type SROI studies [28, 37–41, 47,
48, 56–59, 62, 66] [Table 3].
Data collection for SROI
The SROI methodology is firmly based on retrieving
perspectives of stakeholders [8] (SROI Stage 1) [Fig. 1].
Most SROI studies (29) identified all stakeholders before
choosing which group of stakeholders to include in the
SROI analysis. The remaining 11 studies only considered
beneficiaries [Additional file 3].
A breakdown of stakeholder inclusion for final analysis
following initial consideration revealed that 12 studies
included all stakeholders (beneficiaries, promoters, im-
plementers and funders) [19, 28, 29, 39, 41, 53, 59, 60,
62–64, 66]; 3 studies included beneficiaries and imple-
menters [32, 46, 54]; 2 studies included beneficiaries and
promoters [34, 37]; another 3 studies included benefi-
ciaries, promoters and implementers [44, 48, 50].
Twenty-one studies included only beneficiaries of the
intervention [28, 30, 31, 33, 35, 36, 38, 40, 42, 43, 45, 47,
49, 51, 52, 55–58, 61, 65] [Table 3].
From the included stakeholders, information such as
inputs required for the intervention (costs, time, etc.),
perceived changes experienced by the stakeholder as a
result of the intervention, outcomes benefited or other-
wise from the intervention, duration of the outcome,
relative importance or prioritisation of these outcomes,
changes likely to have occurred in the absence of the
intervention and other factors contributing to the
changes identified were gathered to build the SROI im-
pact map [30, 32, 35, 60].
To gather this information, eight studies used a mix of
qualitative and primary quantitative data [25, 36, 44, 53, 54,
61, 62, 66], 15 studies used a combination of qualitative,
primary quantitative and secondary (existing) quantitative
data [19, 30, 32, 33, 38, 39, 42, 47, 52, 55, 57–60, 65], 9
studies used a combination of qualitative and secondary
quantitative data [29, 39, 41, 43, 45, 46, 56, 63, 64], 3 studies
used only qualitative data [37, 48, 51] and 3 studies used
secondary quantitative data alone [28, 31, 49]. One study
used primary quantitative data alone and another combined
primary and secondary quantitative data [40, 50] [Table 3].
Calculation of SROI ratio
Among the 26 evaluative public health SROI studies, the
median duration between implementation of the inter-
vention and assessment of SROI was 1 year and
Table 3 Findings from systematic review of SROI application in
Public Health
Study characteristics Number of
studies
% of
total
SROI type
Evaluative type 26 65.00
Forecast type 14 35.00
Area of Public Health
Child Health 4 10.00
Environmental Health 1 2.50
Health Care Management 2 5.00
Health Education 1 2.50
Health Promotion 12 30.00
Mental Health 11 27.50
Nutrition 3 7.50
Sexual Reproductive Health 6 15.00
Stakeholders included
Only beneficiaries 21 52.50
Beneficiaries and implementers 3 7.50
Beneficiaries and promoters 2 5.00
Beneficiaries, implementers and
promoters
3 7.50
All stakeholders 11 27.50
Data Source
Qualitative alone 3 7.50
Qualitative + primary 8 20.50
Qualitative + secondary 9 22.50
Qualitative + primary + secondary 15 37.50
Quantitative (primary) alone 1 2.50
Quantitative (secondary) alone 3 7.50
Quantitative (primary + secondary) 1 2.50
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11 months (range of 4 months to 5 years). Meanwhile,
forecast public health SROI studies had a median dur-
ation of 9 years and 5 months (range of 1 to 30 years).
Discount rates, used to account for future value of
costs and benefits [67], varied depending on specific
country recommendation (for example, 3.5 % is recom-
mended in the UK) and this was the justification pro-
vided in all studies for the choice of the discount rate
used in the model [Additional file 3].
SROI ratios varied across the different public health
areas, with the highest ratio of 65.0:1 reported in a study
in child health and the lowest ratio of 1.1:1 reported in a
health promotion SROI study [Table 4]. However, be-
cause of the heterogeneity in the
350 manner of conduct of the SROI studies and in-
deed the economic theory that underpins the SROI
methodology itself, it is not appropriate to compare the
ratios to identify the most impactful or the intervention
with the most value-for-money.
Lessons learnt from previous application of SROI in public
health
Five key themes emerged that captured lessons learnt
from previous SROI application in public health. These
are: 1) use of multiple sources of data improves trust-
worthiness, 2) Purchasing Power Parity (PPP) equiva-
lents improve cost comparability, 3) beneficiaries’ ability
to provide a realistic description and valuation of out-
comes, 4) estimating the counterfactual should be ob-
jectively done and 5) improved transparency required
throughout the SROI process.
Multiple sources of data improves trustworthiness
It is clear that data required for SROI studies is scarce
and both the type and amount of data required are not
routinely collected. One paper suggested that this is the
reason why most SROI studies in developing countries
depended on stakeholder consultations to generate
values to be used to estimate the SROI ratio [36].
“… so for measurement, dependence was mostly on
consultation. This can be further triangulated with
other data sources available internationally” [36].
Generally, practitioners encourage organisations to
gather and keep accurate data, by embedding robust and
rigorous monitoring and evaluation frameworks to as-
sess effect of interventions [64]. Where these monitoring
and evaluation data are not available, then there is a
need to obtain primary data. To improve confidence, ac-
curacy and reliability [68], some authors have triangu-
lated data obtained during a SROI study with existing
secondary data [31, 35, 49, 59] or collected two or three
different types of related primary data [36, 54, 61]. In
cases where there is only one type of secondary data,
data can be triangulated with other types of secondary
data, such as was done by Bhaumik et al., who used
claims from insurance providers to verify patients’
hospital visitations in a community-based care manage-
ment programme for paediatric asthma [31].
Purchasing power parity equivalents improves cost
comparability
Cost and outcomes are financially valued in SROI [8].
However, the value of a “basket of goods” bought with
$1 may differ from the value of the same “basket of
goods” bought with the exchange rate value of $1 in an-
other currency.
“Applying PPP is important in order to ensure that we
do not over value or undervalue goods in different
economies by using a day-to-day exchange rate. After
all, the US$ will buy significantly more in Zambia
than the Zambian Kwacha, which could skew the
findings of the SROI evaluation” [19].
The use of the Purchasing Power Parity (PPP), which
allows for comparability across interventions and across
settings [69], is proposed for valuation of both costs and
outcomes in future SROI studies [19].
Beneficiaries’ ability to provide a realistic description and
valuation of outcomes
SROI attempts to describe outcomes as perceived by a
range of stakeholders, however, it has been suggested
that “true beneficiaries” are better placed, compared to
other stakeholder groups, to determine the outcomes ac-
crued as a result of the intervention. In general, benefi-
ciaries will have experienced the outcome of the
intervention (or lack of the outcome) and can therefore
be expected to provide more realistic valuation of the ef-
fect of the intervention (on them) than stakeholders who
fund, support or implement the intervention [66].
Table 4 Range of SROI ratios by Public Health area
Public health area Minimum SROI ratio Maximum SROI ratio
Child Health 1.85 65.00
Environmental Healtha 26.00 26.00
Health Care Management 1.98 7.00
Health Educationa 7.25 7.25
Health Promotion 1.10 11.00
Mental Health 1.57 11.91
Nutrition 2.05 5.28
Sexual Reproductive Health 1.73 21.20
aOnly one included study
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“Whilst by no means a perfect science, it is important
to note that all monetary values, or financial proxies
used to represent a programme outcome should be
informed by programme beneficiaries” [51].
One study went on to sub-classify the beneficiary
group into first and second tier beneficiaries depending
on their proximity to the primary outcome of the inter-
vention [45].
However, it is generally agreed that stakeholders other
than the “true beneficiaries” (such as: implementers, pro-
moters and funders) remain highly relevant with regard
to the identification of these outcomes and effects that
may be expected to occur following the intervention as
well as in identifying other potential stakeholders and
possibly making recommendations on how to improve
the programme based on expert opinion. In addition,
their engagement and participation through reflexive
consultative processes [57] is essential to ensure that
they clearly understand the needs and perspectives of
the beneficiaries, for whom the intervention is intended.
These are considered gains for organisations keen on
making impact in the community [35, 54].
“… the opportunity to reflect upon the history and
anticipated events that were avoided was beneficial
and enlightening to the group” [35].
To make the process by which beneficiaries assign value
more robust, especially with regard to financial valuation
of effects (or lack of effect) of an intervention, Smith sug-
gested that the financial proxies described by beneficiaries
(which represent the value they place on the outcome in
question), should be tested through further research for
appropriateness and relevance. This could be achieved by
integrating a proxy verification process into existing rou-
tine monitoring and evaluation procedures to ensure that
proxy databases are up to date and reflect current trends
and perceptions of beneficiaries [66].
Estimating the counterfactual should be objectively done
Authors highlight the difficulty in ascertaining what
would have happened in the absence of the intervention;
that is evidence of what is referred to as ‘counterfactual’
[36]. The challenges reported include the need for ex-
haustive data collection, both at baseline and follow-up
as well increased the cost and personnel required to do
this [7].
Some studies have therefore resorted to using subject-
ive assessments to demonstrate the counterfactual. For
example, a study used arbitrary percentage attribution
figures by assuming that attribution is 100 % if the out-
come is completely a result of the intervention and no
other intervention contributed or 75 % if other
interventions had some minor role to play in generating
the outcome or 50 % if contribution was deemed equal
from two different interventions, including the one of
interest and so on [65].
“The issue of how much of the achieved outcome can
be attributable to the programme is difficult to
determine with any level of objectivity, in the absence
of a counterfactual, which is the norm for NGO
implemented programmes of this nature” [36].
However, an estimate of the counterfactual is needed
in order to be able to establish attribution (what portion
of the outcome is specifically due to the intervention)
and this needs to be done in an objective manner, either
by using a before-and-after method or comparing the
intervention group with a control group [41]. Alterna-
tively, mapping out the underlying theory of change at
the design stage of the intervention, which shows the
hypothesised linkage(s) from input to impact of any
intervention will go a long way in aiding establishment
of the counterfactual, as this helps to clearly identify
specific and relevant data required for input, output and
outcomes [19, 34].
Improved transparency required throughout the SROI
process
The most recent guide to conduct SROI includes being
transparent as one of the principles for SROI [8], though
a definition for the concept of “transparency” was not
given. However, borrowing from mainstream research,
transparency is “the benchmark for writing up research
and the presentation and dissemination of findings; that
is, the need to be explicit, clear, and open about the
methods and procedures used” [70]. The guide states
that being transparent would require SROI researchers
to “demonstrate the basis on which the analysis may be
considered accurate and honest, and show that it will be
reported to and discussed with stakeholders” [8].
Practitioners have suggested other concrete methods
to improve transparency of SROI studies. Pank and RM
Insight suggested that an audit trail should be main-
tained throughout the study [38, 50]. Bagley suggested
that a self-assurance process that allows for review of
processes and comparison against benchmarks as set out
in the SROI guidelines should be in place [53]. This
process should detail:
“… how each question within the accreditation criteria
has been addressed within the report and provide
relevant cross-references” [53].
There is also a suggestion to create a formal process of
engaging stakeholders to verify the findings and thus
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increase transparency of the SROI process [30, 54]. The
non-profit organisation, Christian Aid referred to this as
a process of “interrogating the analysis” [34].
“Interrogate this analysis alongside partners to identify
what findings are new and what simply confirm the
findings and conclusions of other studies. Reach
consensus on which parts of the process/analysis were
most useful and instigate a process to include these in
future impact analyses” [34].
Discussion
This systematic review has helped to map the global ap-
plication of the SROI methodology in public health since
its first application in 2005. It has also identified best
practices and lessons learnt from previous SROI studies
in public health. The application of SROI to estimate the
social impact and value for money of interventions is
innovative and results could be used to inform policy
and practice such that the most cost-beneficial interven-
tions are implemented to solve existing public health
challenges [15, 20].
One of the key challenges in conducting this system-
atic review was the identification of SROI studies that
have been conducted in public health. There is no dedi-
cated indexed database for SROI studies. Most SROI
studies are currently published as reports in the grey lit-
erature and do not have key words and abstracts
through which they can be easily retrieved.
To date, the UK is the largest proponent and user of
the SROI methodology. This is consistent with the ef-
forts of the UK Government to stimulate accountability
for wider social, economic and environmental benefits
to society within the Third Sector, as earlier methodolo-
gies were more focused on cost of interventions, effi-
ciency and economies of scale [71, 72]. The steep rise in
the number of SROI studies in public health between
2005 and 2011 is consistent with findings from a previ-
ous systematic review of all SROI studies [21]. This may
have been due to the fact that the Office of the Third
Sector launched the Measuring Social Value project in
2008 [7]. There has been a decline in the use of SROI
after 2011, probably because of the discontinuing stimu-
lus from the government or the inherent challenges
needed to conduct SROI studies including cost, time
and the people- and expertise-dependent nature of the
methodology [6]. However, with the coming into law of
the Social Value Act on 31 January 2013, requiring
people who commission public services to consider how
they can also secure wider social, economic and environ-
mental benefits, the relevance of frameworks such as
SROI is again highlighted [73, 74].
Additionally, there have been renewed efforts recently
to apply the methodology in areas of health such as
global health [75], one health (health of people, animals
and environment) [76, 77], physical health [78] and ma-
ternal health [79]. All these calls recognise that the chal-
lenges that ‘limit’ the application of the methodology are
not unique to SROI itself and indeed a SROI study adds
value with regards to organisational accountability and
reflexivity, which other frameworks rarely offer [6].
Seven SROI studies have been successfully conducted
in low and middle-income countries (LMICs) [19, 29,
34, 36, 43, 51, 66], compared to 33 published studies
from high-income countries [19, 28, 30–33, 35, 37–39,
41, 42, 44–50, 52–65]. This is despite the fact that
LMICs receive the highest amount of aid to fund public
health interventions [80] and arguably need to explore
the use of robust methodologies to assess impact of such
interventions. The reasons for this are not entirely clear.
However, it appears from this review that paucity of reli-
able data may be the main reason for this [36, 81]. Tri-
angulation, which most authors in our review suggested
as a method of improving data accuracy, is a well-known
method for integrating qualitative and quantitative data
[82] and may potentially help to address this reliability
issue. Furthermore, the awareness of the potential of the
methodology to account for social impact of interven-
tions in public health is comparatively low outside the
UK. The UK, Australia and Canada are the only coun-
tries currently with a designated national SROI Network,
with the membership base comprising of anyone with
specific interest in the methodology [83]. Recently, the
SROI Network officially confirmed its merger with the
Social Impact Analysts Association (SIAA) to form So-
cial Value International [84]. This could potentially in-
crease global awareness amongst practitioners and
researchers.
Even within the UK, evidence suggests that SROI stud-
ies are more frequently conducted within the non-profit
sector and there has not been significant application of
the methodology amongst academia, possibly reflected
by the minimal number of SROI studies published in
peer-reviewed journals. The SROI methodology evi-
dently emerged from praxis rather than research, there-
fore, for the methodology to gain wider academic
acceptance, its processes have to be self-reflexive, the
questions being asked have to be clear and well defined,
the methodology replicable and results valid [21, 85].
The rigour required to test and re-test research method-
ology is well developed in academia, which is why aca-
demic inputs would be key for future developments of
the SROI methodology.
Despite generic guidance from the SROI Network
[8, 86], this review has shown that there are differing
opinions on how best to apply the SROI method-
ology. Firstly, there is a need to explore more scien-
tific methods used to account for what would have
Banke-Thomas et al. BMC Public Health  (2015) 15:582 Page 10 of 14
happened with and without the intervention. At present,
most SROI studies use subjective means, such as stake-
holder consultation, to identify and value this. However,
some studies have used a before and after method [35–37,
39–42], while others compared the intervention group
with a control group [19, 28–34, 54]. Both of these
methods are more objective and could potentially increase
the reliability and validity of SROI results. Clearly, there
are situations when neither of these ‘objective means’ is
possible, either for practical or ethical reasons. For such
cases, there is a need to provide clear guidance on how
the effect was valued and how the counterfactual was
determined.
This review also shows that there is no consensus re-
garding which stakeholders should be included to account
for the outcomes of the intervention(s) assessed. Some
authors have included only stakeholders who directly
benefitted from the intervention and not all stakeholder
groups. Those who experienced the outcomes should be
asked to value the benefits (or lack of) themselves; as this
may potentially be a closer to true reflection of the real
impact of public health interventions. Other stakeholders
(implementers, funders or promoters) are not as well
placed to describe experiences of beneficiaries. The prop-
osition here is, if an “investment” has been earmarked for
the benefit of a group of people, then the “return on in-
vestment” should be for what the investment has done for
those people. Inclusion of outcomes from other stake-
holder groups may lead to overestimation of the social
value of the investment, which is not in line with the
principles of the SROI methodology [8]. In addition, previ-
ous impact evaluation methodologies such as the cost-
utility and cost-benefit analysis focus only on the
beneficiaries [87].
For this review, we used Krlev et al.’s 12-point quality
assessment framework. This framework was selected be-
cause it is the first and only publicly available framework
for judging quality of SROI reports. Secondly, the frame-
work incorporates critical and sound research insights,
such as how SROI studies account for what would have
happened without the intervention. We confirmed the
fitness for purpose of the Krlev et al. framework by using
a tool developed by Gough [23]. We also shared the
framework with a SROI practitioner and an impact
evaluation practitioner for their expert opinion, who
both recommended it for use.
There is clearly a need for SROI practitioners and
public health researchers to collaborate in developing a
more widely acceptable and perhaps more robust qual-
ity assessment framework for public health SROI stud-
ies, similar to the Consolidated Health Economic
Evaluation Reporting Standard (CHEERS) framework
for economic evaluations [88]. This is even more
pertinent as the authors of the quality assessment
framework used in this review recognised the limita-
tions [21].
From the findings of this review, it appears that the
quality of public health SROI studies has not signifi-
cantly improved over the years. Some of the more recent
studies did not conduct sensitivity analysis and/or did
not account for the counterfactual scenario objectively
[31, 33, 46, 47, 52, 57, 65]. In contrast, there is an earlier
study, which has fully adhered to the SROI principles
and guidance and accounted for the counterfactual
scenario [36]. Quality seems to be analyst dependent ra-
ther than time dependent (as quality has not improved
over time) or assurance dependent (as the paid internal
peer review service only checks if the conduct has
aligned to the SROI Network principles [89]). This
means that skills of SROI researchers can potentially be
increased through training in the methodology itself.
The assurance process of the SROI Network, which is a
form of peer review, is worth following, though it is con-
sidered inconsistent [90]. The process as it is today
could adopt best practices including a peer review
process such as is used in research proposal and schol-
arly publication (including that peer review is free and
uses people of similar competence to evaluate work of
others) [91].
The Roberts Enterprise Development Fund (REDF) de-
scribed current approaches to SROI as lacking the
systemization and links to established information sys-
tems that can ensure basic levels of reproducible data,
data integrity, and comparability. In a call to action, the
REDF proposed that the “next generation SROI” should
make use of credible financial and social outcomes sys-
tems for collection of costs and outcomes data. The or-
ganisation also proposed that these systems should be
linked so as to increase comparability of results and en-
sure that only meaningful and reliable results will be
generated. This would ultimately lead to wider use of
the model [92]. In this regard, to account for cost varia-
tions and currency exchange rate differences, best prac-
tices such as the use of Purchasing Power Parity (PPP)
value of monies will improve the comparability of re-
sults, at least for similar interventions. In addition, in-
stalling a framework to support conduct of SROI in
programmes at baseline such as was done by Bhaumik
et al. who tracked the number of children visiting emer-
gency department and costs throughout the community
asthma initiative from one year before intervention to
three years after [31], may help to build more reliable
outcomes databases. Only high quality data can yield the
robust values required to account for value for money.
This review needs to be interpreted bearing in mind
the following limitations. Firstly, only published public
health focused SROI studies were included in the review.
There are probably unpublished SROI studies not in the
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public domain. While this is a recognised limitation, at-
tempts were made to request print versions of SROI
studies from any authors that the reviewers became
aware of during the conduct of the review.
Furthermore, the limited number of SROI studies pub-
lished per public health area and the heterogeneity in
conduct of the studies limited the capacity to aggregate
findings from related SROI studies. Finally, the quality of
the SROI studies is a limitation. Overall assessment of
the quality of SROI studies included in this review pro-
vided an above average score. However, a sub-analysis
revealed key weaknesses in choice of design for account-
ing for outcomes. While this does not mean that the
SROI studies themselves do not carry valuable informa-
tion, the conduct of the research could have been better.
There is a need to establish a comprehensive database
to index SROI studies to allow for easier retrieval.
Practitioners need to engage with academics to develop
the methodology further and clear guidance is needed to
systematise the procedures for applying the SROI
methodology.
Conclusions
The international development community continues to
invest significantly in public health. A culture of
accountability and “value for money” is central to moni-
toring and evaluation of public health projects, pro-
grammes and policies. In times of austerity, robust and
innovative tools are needed. The SROI methodology
provides a platform to systematically account for broader
outcomes of interventions and the value for money of
such interventions. SROI is very relevant and applicable,
especially as the global focus shifts from “output” to “im-
pact” and from “generous giving” to “accountable giving”
[94]. It aids identification of the most impactful, cost-
beneficial and culturally sensitive public health interven-
tions. It is however clear that the methodology will
benefit from increased synergy between SROI practi-
tioners and public health researchers in order to be able
to account for the real and broad impact of interven-
tions more robustly.
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